Grantham, Mayo, Van Otterloo & Co (GMO)’s Parker-Hannifin PH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$505K Buy
529
+12
+2% +$11.8K ﹤0.01% 598
2026
Q2
$506K Buy
+517
New +$474K ﹤0.01% 568
2023
Q4
– Sell
-3,432
Closed -$1.34M – 563
2023
Q3
$1.34M Buy
+3,432
New +$1.38M 0.01% 434
2022
Q3
– Sell
-2,500
Closed -$615K – 773
2022
Q2
$615K Sell
2,500
-2,522
-50% -$675K ﹤0.01% 584
2022
Q1
$1.42M Sell
5,022
-7,000
-58% -$2.11M 0.01% 482
2021
Q4
$3.82M Sell
12,022
-11,388
-49% -$3.52M 0.02% 374
2021
Q3
$6.55M Sell
23,410
-12,852
-35% -$3.82M 0.03% 299
2021
Q2
$11.1M Buy
36,262
+14,829
+69% +$4.59M 0.06% 238
2021
Q1
$6.76M Buy
21,433
+12,371
+137% +$3.57M 0.04% 277
2020
Q4
$2.47M Buy
9,062
+1,900
+27% +$471K 0.02% 403
2020
Q3
$1.45M Buy
7,162
+1,562
+28% +$307K 0.01% 462
2020
Q2
$1.03M Sell
5,600
-100
-2% -$16.1K 0.01% 525
2020
Q1
$739K Buy
+5,700
New +$1.03M 0.01% 545
2018
Q4
– Sell
-19,359
Closed -$3.56M – 574
2018
Q3
$3.56M Sell
19,359
-16,830
-47% -$2.89M 0.02% 248
2018
Q2
$5.64M Sell
36,189
-35,441
-49% -$6.04M 0.04% 199
2018
Q1
$12.3M Sell
71,630
-20,000
-22% -$3.79M 0.07% 142
2017
Q4
$18.3M Sell
91,630
-2,700
-3% -$502K 0.11% 110
2017
Q3
$16.5M Buy
94,330
+16,000
+20% +$2.63M 0.1% 126
2017
Q2
$12.5M Buy
78,330
+28,200
+56% +$4.47M 0.07% 164
2017
Q1
$8.04M Buy
50,130
+26,830
+115% +$4.07M 0.05% 196
2016
Q4
$3.26M Buy
23,300
+21,400
+1,126% +$2.85M 0.02% 274
2016
Q3
$239K Buy
+1,900
New +$226K ﹤0.01% 458
2016
Q2
– Sell
-10,500
Closed -$1.17M – 613
2016
Q1
$1.17M Sell
10,500
-300
-3% -$30.1K ﹤0.01% 409
2015
Q4
$1.05M Sell
10,800
-2,600
-19% -$263K ﹤0.01% 391
2015
Q3
$1.3M Sell
13,400
-100
-0.7% -$10.9K ﹤0.01% 376
2015
Q2
$1.57M Buy
13,500
+1,600
+13% +$193K 0.01% 333
2015
Q1
$1.41M Sell
11,900
-400
-3% -$48.5K ﹤0.01% 348
2014
Q4
$1.59M Buy
+12,300
New +$1.51M ﹤0.01% 339

Other funds holding PH

Grantham, Mayo, Van Otterloo & Co (GMO)'s PH Position: Q3 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Parker-Hannifin (PH) stake by 2.3% in Q3 2026, buying an estimated $11.8K and bringing the position to 529 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #598.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PH in Q4 2014 and has held it in 28 quarters since. The position peaked at $18.3M in Q4 2017. 1,714 funds tracked by Wall St. Rank hold PH as of Q3 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 529 shares of Parker-Hannifin worth $505K as of Q3 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 12 Parker-Hannifin shares in Q3 2026, an estimated $11.8K.
  • Parker-Hannifin made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q3 2026, its #598 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Parker-Hannifin in Q4 2014 and has held it in 28 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Parker-Hannifin position peaked at $18.3M in Q4 2017.
  • 1,714 funds tracked by Wall St. Rank held Parker-Hannifin as of Q3 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2026, filed 13 Nov 2026.